Cancer Research | Penn Today

CRISPR cancer trial success paves the way for personalized treatments

Joseph Fraietta of the Perelman School of Medicine explains the complicated manufacturing process behind T-cell cancer therapies.

Meg Ruller with her dog Maple in front of Penn Vet

A FLASH of radiation may pave the way toward new cancer care for people and pets alike

Led by the Perelman School of Medicine’s Keith Cengel and the School of Veterinary Medicine’s Brian Flesner, a new study is evaluating the safety and efficacy of treating oral cancer in dogs with a palliative radiation in just two clinic visits.

happy looking golden retriever in a clinic's kennel area

NIH-funded canine immunotherapy data center charts a path toward transformative therapies

With support recently granted for five more years, Nicola Mason of the School of Veterinary Medicine and Qi Long of the Perelman School of Medicine hope their work leads to new insights in cancer care for people as well as pets.

After giving up on cancer vaccines, doctors start to find hope

Susan Domchek of the Perelman School of Medicine foresees a time when anyone with a precancerous condition or a predisposition to cancer can be vaccinated and protected.

YOUR HEALTH: Skip the chemo, future cancer breakthrough?

Penn collaborated in research that discovered engineering t-cells with a lab-made receptor called i-l-9 allows the cancer-fighting cells to do their work without the need for chemo or radiation.

Eight Penn scientists receive NIH grants through High-Risk, High-Reward Research program

A group of five scientists received the Transformative Research Award for a project focusing on cancer research, while three investigators received the New Innovator Award for independent projects developed by early-career investigators.

The race to make a vaccine for breast cancer

Robert Vonderheide of the Abramson Cancer Center at the Perelman School of Medicine talks about his work on a vaccine to prevent cancers for the rest of people’s lives.

Armored CAR T cells break through immune suppression in solid tumors

A study by Joseph Fraietta of the Perelman School of Medicine and colleagues found a way to “armor” CAR T cells, enabling them to get past immunosuppressors in prostate cancer.

University of Pennsylvania receives $55 million gift to study, treat hereditary cancers

The $55 million gift from alumni Mindy and Jon Gray will be used to establish the Basser Cancer Interception Institute, featuring a statement from President Liz Magill.

Understanding the needs of cancer care partners

Through the Penn Undergraduate Research Mentoring Program, undergrads Abi Ocholi and Akin Adio deepened their understanding of qualitative research and of the experiences of caregivers.

Filters